CD8A and neoplasm: Consequently, based on the high plasticity of macrophages, reversing the proportion of different macrophage subsets, and then recruiting and activating CD8+ T cells to achieve better tumor killing in the tumor microenvironment will be a feasible and suitable cancer immunotherapeutic approach.